- Home
- DNN vs PCRX Comparison
DNN vs PCRX Comparison
Compare DNN & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNN
- PCRX
- Stock Information
- Founded
- DNN 1936
- PCRX 2006
- Country
- DNN Canada
- PCRX United States
- Employees
- DNN N/A
- PCRX N/A
- Industry
- DNN Other Metals and Minerals
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- DNN Basic Materials
- PCRX Health Care
- Exchange
- DNN Nasdaq
- PCRX Nasdaq
- Market Cap
- DNN 1.2B
- PCRX 1.1B
- IPO Year
- DNN 1997
- PCRX 2011
- Fundamental
- Price
- DNN $1.39
- PCRX $22.69
- Analyst Decision
- DNN Strong Buy
- PCRX Buy
- Analyst Count
- DNN 2
- PCRX 9
- Target Price
- DNN $3.00
- PCRX $26.22
- AVG Volume (30 Days)
- DNN 63.8M
- PCRX 823.4K
- Earning Date
- DNN 05-07-2025
- PCRX 05-06-2025
- Dividend Yield
- DNN N/A
- PCRX N/A
- EPS Growth
- DNN N/A
- PCRX N/A
- EPS
- DNN N/A
- PCRX N/A
- Revenue
- DNN $2,920,167.00
- PCRX $700,966,000.00
- Revenue This Year
- DNN $226.79
- PCRX $9.77
- Revenue Next Year
- DNN $133.88
- PCRX $9.83
- P/E Ratio
- DNN N/A
- PCRX N/A
- Revenue Growth
- DNN N/A
- PCRX 3.85
- 52 Week Low
- DNN $1.27
- PCRX $11.16
- 52 Week High
- DNN $2.47
- PCRX $31.67
- Technical
- Relative Strength Index (RSI)
- DNN 37.82
- PCRX 40.27
- Support Level
- DNN $1.27
- PCRX $21.83
- Resistance Level
- DNN $1.45
- PCRX $24.23
- Average True Range (ATR)
- DNN 0.10
- PCRX 1.22
- MACD
- DNN 0.00
- PCRX -0.36
- Stochastic Oscillator
- DNN 35.94
- PCRX 17.70
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company with interests focused in the Athabasca Basin region of northern Saskatchewan, Canada. The company has an effective 95% interest in its flagship Wheeler River Uranium Project, which is the largest undeveloped uranium project in the infrastructure-rich eastern portion of the Athabasca Basin region of northern Saskatchewan. The company is also engaged in mine decommissioning and environmental services through its Closed Mines group, which manages its Elliot Lake reclamation projects and provides third-party post-closure mine care and maintenance services.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.